These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16296750)

  • 1. Epidermal delivery of protein and DNA vaccines.
    Dean HJ
    Expert Opin Drug Deliv; 2005 Mar; 2(2):227-36. PubMed ID: 16296750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis.
    Dean HJ; Fuller D; Osorio JE
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):373-88. PubMed ID: 12818623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needle-free epidermal powder immunization.
    Chen D; Maa YF; Haynes JR
    Expert Rev Vaccines; 2002 Oct; 1(3):265-76. PubMed ID: 12901567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal DNA vaccine for influenza is immunogenic in humans.
    Drape RJ; Macklin MD; Barr LJ; Jones S; Haynes JR; Dean HJ
    Vaccine; 2006 May; 24(21):4475-81. PubMed ID: 16150518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of the venturi effect to introduce micro-particles for epidermal vaccination.
    Liu Y
    Med Eng Phys; 2007 Apr; 29(3):390-7. PubMed ID: 16843696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and immune responses in humans to a PowderJect DNA vaccine for hepatitis B.
    Swain WE; Heydenburg Fuller D; Wu MS; Barr LJ; Fuller JT; Culp J; Burkholder J; Dixon RM; Widera G; Vessey R; Roy MJ
    Dev Biol (Basel); 2000; 104():115-9. PubMed ID: 11713809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical safety assessment of a DNA vaccine using particle-mediated epidermal delivery in domestic pig, minipig and mouse.
    Dincer Z; Jones S; Haworth R
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):351-7. PubMed ID: 16713213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
    Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG
    Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of noncarrier naked DNA vaccine into the skin by supersonic flow induces a polarized T helper type 1 immune response to cancer.
    Lin CC; Yen MC; Lin CM; Huang SS; Yang HJ; Chow NH; Lai MD
    J Gene Med; 2008 Jun; 10(6):679-89. PubMed ID: 18324638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device.
    Roberts LK; Barr LJ; Fuller DH; McMahon CW; Leese PT; Jones S
    Vaccine; 2005 Sep; 23(40):4867-78. PubMed ID: 15985318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal powder immunization against influenza.
    Dean HJ; Chen D
    Vaccine; 2004 Dec; 23(5):681-6. PubMed ID: 15542190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery.
    Sharpe M; Lynch D; Topham S; Major D; Wood J; Loudon P
    Vaccine; 2007 Aug; 25(34):6392-8. PubMed ID: 17640779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Needle-free delivery of veterinary DNA vaccines.
    van Drunen Littel-van den Hurk S; Babiuk S; Babiuk LA
    Methods Mol Med; 2006; 127():91-105. PubMed ID: 16988449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering of needle-free physical methods to target epidermal cells for DNA vaccination.
    Kendall M
    Vaccine; 2006 May; 24(21):4651-6. PubMed ID: 16162368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Companies Claim to Fame and their scientific challenges in vaccine development.
    Boon L
    Immunol Lett; 2009 Feb; 122(2):123-5. PubMed ID: 19101592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing particle-mediated epidermal delivery of an influenza DNA vaccine in ferrets.
    Yager EJ; Stagnar C; Gopalakrishnan R; Fuller JT; Fuller DH
    Methods Mol Biol; 2013; 940():223-37. PubMed ID: 23104347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity.
    Ohba K; Yoshida S; Zahidunnabi Dewan M; Shimura H; Sakamaki N; Takeshita F; Yamamoto N; Okuda K
    Vaccine; 2007 May; 25(21):4291-300. PubMed ID: 17403560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FluBlok, a recombinant influenza vaccine.
    Huber VC; McCullers JA
    Curr Opin Mol Ther; 2008 Feb; 10(1):75-85. PubMed ID: 18228185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.